Related Experiment Videos
Peripartum cardiomyopathy: a comprehensive review
1Department of Internal Medicine, University of Florida Health Science Center, Gainesville 32610, USA.
American Journal of Obstetrics and Gynecology
|March 21, 1998
Summary
Peripartum cardiomyopathy (PPCM) affects about 1000 US women annually, often proving fatal. Early recognition and treatment by healthcare providers are crucial for managing this heart condition.
Area of Science:
- Cardiology
- Obstetrics
- Internal Medicine
Background:
- Peripartum cardiomyopathy (PPCM) is a rare form of heart failure.
- It affects women in the final month of pregnancy or within five months of delivery.
- PPCM has a significant mortality rate.
Purpose of the Study:
- To review the etiology, diagnosis, treatment, prognosis, and natural history of PPCM.
- To highlight the importance of early recognition and management by primary care physicians and obstetricians.
Main Methods:
- Comprehensive review of English language medical literature from 1966 to present via MEDLINE and cross-referencing.
- Meta-analysis was not feasible due to limited study numbers.
Main Results:
- The etiology of PPCM remains uncertain, with current evidence suggesting myocarditis (viral, autoimmune, or idiopathic).
- Immunosuppressive therapy's utility is ambiguous.
- Advances in medical therapy for dilated cardiomyopathy and cardiac transplantation have improved patient outcomes.
Conclusions:
- Early diagnosis and prompt medical management of the congestive state are critical for PPCM patients.
- Obstetricians and family practitioners play a vital role in initial patient contact and management.
- Improved therapies offer better quality of life and survival rates.